Episode 128: Testicular Cancer Series, Pt 2 -...

This week, we are so excited to share the first of our Career Development Series episodes, developed in partnership with The American Society of Hematology , The ASH Trainee Council, and Hematopoiesis! For years, our listeners have reached out to our show asking for guidance to h ...  Show more

This week, we begin our discussion about treatment of multiple myeloma, focusing on the first-line setting. Once again, a lot has changed in this space over the last few years, most notably the standards of care (now quadruplet regimens instead of triplet regimens!). We break dow ...  Show more

Our second SABCS (San Antonio Breast Cancer Symposium) episode covers everything (else) you need to know from 2024.

In this episode, we dive into the role of trastuzumab deruxtecan in HR +ve, HER2 low cancers, perioperative atezolizumab in tnbc, the use of a novel A ...

Join Jame and Callum as they discuss this paper which examines where these new antibiotics are going, and why they aren't widely available.Notes for this episode here Support the showWe are currently seeking more detailed feedback, please help us improve the podcast by giving you ...  Show more

In this podcast, I continue to delve into MSK concepts the USMLEs consider to be relevant for Step 1-3 by discussing NBME pathologies relating to the knees and hip. Short podcast but very HY for your test. Audio Download 

This is the last episode of our core curriculum series. In this episode we discuss cancer survivorship as it relates to gynecologic oncology. Additionally we provide a framework for surveillance visits as well the general timing based on primary malignancy. We also give a brief o ...  Show more